AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $62,000 | -19.5% | 1,355 | -3.2% | 0.00% | 0.0% |
| Q2 2021 | $77,000 | -4.9% | 1,400 | -10.8% | 0.00% | 0.0% |
| Q1 2021 | $81,000 | +17.4% | 1,570 | -1.9% | 0.00% | -50.0% |
| Q4 2020 | $69,000 | +245.0% | 1,600 | +171.2% | 0.00% | +100.0% |
| Q3 2020 | $20,000 | +17.6% | 590 | +40.5% | 0.00% | -50.0% |
| Q4 2016 | $17,000 | -5.6% | 420 | +21.7% | 0.00% | 0.0% |
| Q3 2016 | $18,000 | +100.0% | 345 | +66.7% | 0.00% | +100.0% |
| Q2 2016 | $9,000 | +80.0% | 207 | +58.0% | 0.00% | – |
| Q1 2016 | $5,000 | +25.0% | 131 | +111.3% | 0.00% | – |
| Q4 2015 | $4,000 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |